NeuroDiscovery Ltd - Product Pipeline Review - Q1 2011

Global Markets Direct, May 2011, Pages: 23

NeuroDiscovery Ltd – Product Pipeline Review – Q1 2011

Summary

Global Market Direct’s pharmaceuticals report, “NeuroDiscovery Ltd - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- NeuroDiscovery Ltd - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of NeuroDiscovery Ltd human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of NeuroDiscovery Ltd with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the NeuroDiscovery Ltd’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate NeuroDiscovery Ltd’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of NeuroDiscovery Ltd in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the NeuroDiscovery Ltd’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with NeuroDiscovery Ltd.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of NeuroDiscovery Ltd and identify potential opportunities in those areas.

List of Tables
List of Figures
NeuroDiscovery Ltd Snapshot
NeuroDiscovery Ltd Overview
Key Information
Key Facts
NeuroDiscovery Ltd – Research and Development Overview
Key Therapeutic Areas
NeuroDiscovery Ltd – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
NeuroDiscovery Ltd – Pipeline Products Glance
NeuroDiscovery Ltd Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
NeuroDiscovery Ltd–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
NeuroDiscovery Ltd – Drug Profiles
NSL-101
Product Description
Mechanism of Action
R&D Progress
NSL-043
Product Description
Mechanism of Action
R&D Progress
NSL-036
Product Description
Mechanism of Action
R&D Progress
NSL-105
Product Description
Mechanism of Action
R&D Progress
NeuroDiscovery Ltd – Pipeline Analysis
NeuroDiscovery Ltd – Pipeline Products by Therapeutic Class
NeuroDiscovery Ltd – Pipeline Products by Route of Administration
NeuroDiscovery Ltd - Dormant Projects
NeuroDiscovery Ltd - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
NSL-036
NeuroDiscovery Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Financial Deals Landscape
NeuroDiscovery Ltd, Deals Summary, 2004 to 2011
NeuroDiscovery Ltd Detailed Deal Summary
NeuroDiscovery Enters Into Co-Marketing Agreement With Pharmidex
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
NeuroDiscovery Ltd – Pipeline by Therapy Area and Indication, 2011
NeuroDiscovery Ltd – Pipeline by Stage of Development, 2011
NeuroDiscovery Ltd – Monotherapy Products in Pipeline, 2011
NeuroDiscovery Ltd - Phase II, 2011
NeuroDiscovery Ltd - Phase I, 2011
NeuroDiscovery Ltd - Pipeline By Therapeutic Class, 2011
NeuroDiscovery Ltd – Pipeline By Route of Administration, 2011
NeuroDiscovery Ltd - Dormant Developmental Projects, 2010
NeuroDiscovery Ltd - Discontinued Pipeline Products, 2010
NeuroDiscovery Ltd, Subsidiaries
NeuroDiscovery Ltd, Deals Summary, 2004 to 2011

List of Figures
NeuroDiscovery Ltd – Pipeline by Therapy Area and Indication, 2011
NeuroDiscovery Ltd – Pipeline by Stage of Development, 2011
NeuroDiscovery Ltd – Monotherapy Products in Pipeline, 2011
NeuroDiscovery Ltd – Pipeline By Therapeutic Class, 2011

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Scientific Games Corporation - Company Analysis
• eBay - Strong Execution
• SunGard - Profile - US
• Abbott Laboratories - IT Sales Opportunities - 2009
• Amazon - Point of Realization in 2013?
• Insight into Samsung Electronics' Notebook PC Business Model
• Ixia - Company Analysis